Hogg RS - Search Results

1

Health-adjusted life expectancy in HIV-positive and HIV-negative men and women in British Columbia, Canada: a population-based observational cohort study.

Hogg RS, Eyawo O, Collins AB, Zhang W, Jabbari S, Hull MW, Lima VD, Ahmed T, Kendall CE, Althoff KN, Justice AC, Barrios R, Shoveller J, Montaner JSG; Comparative Outcomes And Service Utilization Trends (COAST) study. Hogg RS, et al. Lancet HIV. 2017 Jun;4(6):e270-e276. doi: 10.1016/S2352-3018(17)30029-2. Epub 2017 Mar 3. Lancet HIV. 2017. PMID: 28262574 Free PMC article.

2

Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme.

Wood E, Tyndall MW, Spittal PM, Li K, Hogg RS, Montaner JS, O'Shaughnessy MV, Schechter MT. Wood E, et al. Among authors: hogg rs. AIDS. 2002 Apr 12;16(6):941-3. doi: 10.1097/00002030-200204120-00021. AIDS. 2002. PMID: 11919503

3

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up.

Hogg RS, Heath K, Bangsberg D, Yip B, Press N, O'Shaughnessy MV, Montaner JS. Hogg RS, et al. AIDS. 2002 May 3;16(7):1051-8. doi: 10.1097/00002030-200205030-00012. AIDS. 2002. PMID: 11953472

4

Prescribing practices in a population-based HIV postexposure prophylaxis program.

Braitstein P, Chan K, Beardsell A, McLeod A, Montaner JS, O'Shaughnessy MV, Hogg RS. Braitstein P, et al. Among authors: hogg rs. AIDS. 2002 May 3;16(7):1067-70. doi: 10.1097/00002030-200205030-00014. AIDS. 2002. PMID: 11953474

5

To stop or not to stop: that is the question, but what is the answer?

Hogg RS, Havlir D, Miller V, Montaner JS. Hogg RS, et al. AIDS. 2002 Mar 29;16(5):787-9. doi: 10.1097/00002030-200203290-00015. AIDS. 2002. PMID: 11964536 No abstract available.

6

"Discordant" increases in CD4 cell count relative to plasma viral load in a closely followed cohort of patients initiating antiretroviral therapy.

Wood E, Hogg RS, Yip B, Tyndall MW, Sherlock CH, Harrigan RP, O'Shaughnessy MV, Montaner JS. Wood E, et al. Among authors: hogg rs. J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):159-66. doi: 10.1097/00042560-200206010-00004. J Acquir Immune Defic Syndr. 2002. PMID: 12045678 Clinical Trial.

7

Antiretroviral treatment patterns and incident HIV-associated morphologic and lipid abnormalities in a population-based chort.

Heath KV, Hogg RS, Singer J, Chan KJ, O'Shaughnessy MV, Montaner JS. Heath KV, et al. Among authors: hogg rs. J Acquir Immune Defic Syndr. 2002 Aug 1;30(4):440-7. doi: 10.1097/00042560-200208010-00010. J Acquir Immune Defic Syndr. 2002. PMID: 12138351

8

Survival rates after the initiation of antiretroviral therapy stratified by CD4 cell counts in two cohorts in Canada and the United States.

Chan KC, Yip B, Hogg RS, Montaner JS, O'Shaughnessy MV. Chan KC, et al. Among authors: hogg rs. AIDS. 2002 Aug 16;16(12):1693-5. doi: 10.1097/00002030-200208160-00020. AIDS. 2002. PMID: 12172096 No abstract available.

9

No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy.

Brumme ZL, Chan KJ, Dong WW, Mo T, Wynhoven B, Hogg RS, Montaner JS, O'Shaughnessy MV, Harrigan PR. Brumme ZL, et al. Among authors: hogg rs. AIDS. 2002 Sep 27;16(14):1929-33. doi: 10.1097/00002030-200209270-00010. AIDS. 2002. PMID: 12351953

10

Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996.

Wood E, Montaner JS, Chan K, Tyndall MW, Schechter MT, Bangsberg D, O'Shaughnessy MV, Hogg RS. Wood E, et al. Among authors: hogg rs. AIDS. 2002 Oct 18;16(15):2065-72. doi: 10.1097/00002030-200210180-00012. AIDS. 2002. PMID: 12370506

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

594 results

Search Page

Filters